Obesity Hypoventilation Syndrome Prevalence Study

N/ATerminatedNCT01964339

Philips Respironics44 enrolled

Overview

This is an observational study to characterize the prevalence of Obesity Hypoventilation Syndrome in patients referred to the sleep lab.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Obesity Hypoventilation Syndrome

Interventions

BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.OTHER

Venous blood gas, basic metabolic panel, PSG variable data collection.

BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.OTHER

Arterial blood gas, basic metabolic panel, PSG variable data collection

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Greater than or equal to 21 yrs. of age * Referred to sleep lab for diagnostic PSG, initial titration PSG or split night PSG as routine clinical care * BMI greater than or equal to 30kg/m2 Exclusion Criteria: * Acutely ill or medically unstable to participate per PI * Current positive airway pressure(PAP therapy)users * Medical History of Chronic Obstructive Pulmonary Disease(COPD) * Incapable of providing own informed consent * BMI less than 30kg/m2

Locations (1)

Ochsner Baptist Medical Center

New Orleans, Louisiana, United States

Outcomes

Primary Outcomes

Baseline venous blood draw

The study involves a venipuncture and data collection at the time of sleep study. Data collection will be correlated to blood draw results.

Time frame: single blood draw

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.